Pfizer, BioNTech testing COVID-19 vaccine in children under 12

By: Alyssa Wilson

Pfizer Inc. and BioNTech have begun testing their COVID-19 vaccine in children under the age of 12. 

The companies hope to expand vaccination to the age group by 2022, according to Reuters

Children as young as six months old will participate in the pediatric trial.

RELATED:  Dr. Fauci on COVID-19 vaccine: we must respect the concerns of the Black community

Volunteers in the trial were given their first injections on Wednesday, a Pfizer spokesperson said. 

Currently, the Pfizer-BioNTech vaccine is used in people 16 years old and older, while the Moderna vaccine is not cleared for people under the age of 18. 

No COVID-19 vaccine has been authorized for children to use. 

According to NBC News, there will be 144 participants and the trial will examine whether the vaccine can generate an immune response in children. 

Data from the CDC revealed that there are fewer cases of COVID-19 reported in kids compared to adults. 

RELATED: CDC: Fully vaccinated people can gather without masks, social distancing


Latest in News


Philadelphia Hits Disturbing Record of 500 Homicides


Nigerian Singer Davido’s Birthday Requests Becomes Act of Charity


Hulu Releases Documentary on Janet Jackson Wardrobe Malfunction

Dr. Kariamu Welsh Dies


Restorative Justice: Charges Dropped Against Officer Who Shot Black Woman


President Biden Chooses Shalanda Young to Lead White House Budget Office

Beyoncé and Jay-Z


Jay-Z Surpasses Quincy Jones as Highest Grammy Nominated Artist


Astronaut Jessica Watkins To Be First Black Woman on Space Station


Former Capitol Police Officer Files Lawsuit Alleging Discrimination